Engineering of human-type O-glycosylation in Nicotiana benthamiana plants

Bioengineered

Volumn 4, Issue 4, 2013, Pages 191-196

  Strasser, Richard ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Erythropoietin; Glycoprotein; Glycosylation; Molecular farming; Posttranslational modification; Recombinant protein; Sialic acid

Indexed keywords

ERYTHROPOIETIN; FUCOSE; GLYCAN DERIVATIVE; GLYCOSYLTRANSFERASE; HYBRID PROTEIN; N ACETYLGALACTOSAMINE; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; RECOMBINANT PROTEIN; SIALIC ACID;

ARTICLE; CELL LINE; GLYCOPROTEIN SYNTHESIS; GOLGI COMPLEX; HUMAN; NICOTIANA BENTHAMIANA; NONHUMAN; PROTEIN ENGINEERING; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; RHIZOBIUM RADIOBACTER; TRANSGENIC PLANT; TRANSIENT EXPRESSION;

ERYTHROPOIETIN; GLYCOPROTEIN; GLYCOSYLATION; MOLECULAR FARMING; POSTTRANSLATIONAL MODIFICATION; RECOMBINANT PROTEIN; SIALIC ACID;

GLYCOSYLATION; HUMANS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; TOBACCO;

EID: 84883212921     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bioe.22857     Document Type: Article

References (52)

1. Fischer R, Schillberg S, Hellwig S, Twyman RM, Drossard J. GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol Adv 2012; 30:434-439; PMID:21856403; http://dx.doi.org/10.1016/j.biotechadv.2011.08.007.
2. Maxmen A. Drug-making plant blooms. Nature 2012; 485:160; PMID:22575938; http://dx.doi.org/10.1038/485160a.
3. Bendandi M, Marillonnet S, Kandzia R, Thieme F, Nickstadt A, Herz S, et al. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann Oncol 2010; 21:2420-2427; PMID:20494963; http://dx.doi.org/10.1093/annonc/mdq256.
4. Sainsbury F, Sack M, Stadlmann J, Quendler H, Fischer R, Lomonossoff GP. Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody. PLoS One 2010; 5:e13976; PMID:21103044; http://dx.doi.org/10.1371/journal.pone.0013976.
5. Castilho A, Bohorova N, Grass J, Bohorov O, Zeitlin L, Whaley K, et al. Rapid high yield production of different glycoforms of Ebola virus monoclonal antibody. PLoS One 2011; 6:e26040; PMID:22039433; http://dx.doi.org/10.1371/journal.pone.0026040.
6. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 2002; 277:26733-26740; PMID:11986321; http://dx.doi.org/10.1074/jbc.M202069200.
7. Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A. Production platforms for biotherapeutic glyco-proteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev 2012; 28:147-175; PMID:22616486; http://dx.doi.org/10.5661/bger-28-147.
8. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypep-tide GalNAc-transferase gene family. Glycobiology 2012; 22:736-756; PMID:22183981; http://dx.doi.org/10.1093/glycob/cwr182.
9. Schjoldager K T, Clausen H. Site-specific protein O-glycosylation modulates proprotein processing-Deciphering specific functions of the large poly-peptide GalNAc-transferase gene family. Biochim Biophys Acta 2012; 1820:2079-2094.
10. Schiestl M, Stangler T, Torella C, Cepeljnik T, Toll H, Grau R. Acceptable changes in quality attributes of glycosylated biopharmaceuticals. Nat Biotechnol 2011; 29:310-312; PMID:21478841; http://dx.doi.org/10.1038/nbt.1839.
11. Taschwer M, Hackl M, Hernández Bort JA, Leitner C, Kumar N, Puc U, et al. Growth, productivity and protein glycosylation in a CHO EpoFc producer cell line adapted to glutamine-free growth. J Biotechnol 2012; 157:295-303; PMID:22178781; http://dx.doi.org/10.1016/j.jbiotec.2011.11.014.
12. Boisson M, Gomord V, Audran C, Berger N, Dubreucq B, Granier F, et al. Arabidopsis glucosi-dase I mutants reveal a critical role of N-glycan trimming in seed development. EMBO J 2001; 20:1010-1019; PMID:11230125; http://dx.doi.org/10.1093/emboj/20.5.1010.
13. Gillmor CS, Poindexter P, Lorieau J, Palcic MM, Somerville C. Alpha-glucosidase I is required for cellulose biosynthesis and morphogenesis in Arabidopsis. J Cell Biol 2002; 156:1003-1013; PMID:11901167; http://dx.doi.org/10.1083/jcb.200111093.
14. Soussilane P, D'Alessio C, Paccalet T, Fitchette AC, Parodi AJ, Williamson R, et al. N-glycan trimming by glucosidase II is essential for Arabidopsis development. Glycoconj J 2009; 26:597-607; PMID:18972207; http://dx.doi.org/10.1007/s10719-008-9201-1.
15. Liebminger E, Hüttner S, Vavra U, Fischl R, Schoberer J, Grass J, et al. Class I alpha-manno-sidases are required for N-glycan processing and root development in Arabidopsis thaliana. Plant Cell 2009; 21:3850-3867; PMID:20023195; http://dx.doi.org/10.1105/tpc.109.072363.
16. Altmann F. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007; 142:99-115; PMID:17033195; http://dx.doi.org/10.1159/000096114.
17. Strasser R, Altmann F, Mach L, Glössl J, Steinkellner H. Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. FEBS Lett 2004; 561:132-136; PMID:15013764; http://dx.doi.org/10.1016/S0014-5793(04)00150-4.
18. Koprivova A, Stemmer C, Altmann F, Hoffmann A, Kopriva S, Gorr G, et al. Targeted knockouts of Physcomitrella lacking plant-specific immuno-genic N-glycans. Plant Biotechnol J 2004; 2:517-523; PMID:17147624; http://dx.doi.org/10.1111/j.1467-7652.2004.00100.x.
19. Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, Peele CG, et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 2006; 24:1591-1597; PMID:17128273; http://dx.doi.org/10.1038/nbt1260.
20. Strasser R, Stadlmann J, Schähs M, Stiegler G, Quendler H, Mach L, et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 2008; 6:392-402; PMID:18346095; http://dx.doi.org/10.1111/j.1467-7652.2008.00330.x.
21. Shin YJ, Chong YJ, Yang MS, Kwon TH. Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol J 2011; 9:1109-1119; PMID:21801300; http://dx.doi.org/10.1111/j.1467-7652.2011.00636.x.
22. Strasser R, Castilho A, Stadlmann J, Kunert R, Quendler H, Gattinger P, et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous β1,4-galactosylated N-glycan profile. J Biol Chem 2009; 284:20479-20485; PMID:19478090; http://dx.doi.org/10.1074/jbc.M109.014126.
23. Castilho A, Strasser R, Stadlmann J, Grass J, Jez J, Gattinger P, et al. In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 2010; 285:15923-15930; PMID:20305285; http://dx.doi.org/10.1074/jbc.M109.088401.
24. Forthal DN, Gach JS, Landucci G, Jez J, Strasser R, Kunert R, et al. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol 2010; 185:6876-6882; PMID:21041724; http://dx.doi.org/10.4049/jimmunol.1002600.
25. Castilho A, Gattinger P, Grass J, Jez J, Pabst M, Altmann F, et al. N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 2011; 21:813-23; PMID:21317243; http://dx.doi.org/10.1093/glycob/cwr009.
26. Nagels B, Van Damme EJ, Pabst M, Callewaert N, Weterings K. Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol 2011; 155:1103-1112; PMID:21233332; http://dx.doi.org/10.1104/pp.110.168773.
27. Velasquez M, Salter JS, Dorosz JG, Petersen BL, Estevez JM. Recent advances on the posttranslational modifications of EXTs and their roles in plant cell walls. Front Plant Sci 2012; 3:93; PMID:22639676; http://dx.doi.org/10.3389/fpls.2012.00093.
28. Karnoup AS, Turkelson V, Anderson WH. O-linked glycosylation in maize-expressed human IgA1. Glycobiology 2005; 15:965-81; PMID:15901675; http://dx.doi.org/10.1093/glycob/cwi077.
29. Pinkhasov J, Alvarez ML, Rigano MM, Piensook K, Larios D, Pabst M, et al. Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice. Plant Biotechnol J 2011; 9:991-1001; PMID:21740504; http://dx.doi.org/10.1111/j.1467-7652.2011.00614.x.
30. Yang Z, Drew DP, Jorgensen B, Mandel U, Bach SS, Ulvskov P, et al. Engineering mammalian mucin-type O-glycosylation in plants. J Biol Chem 2012; 287:11911-11923; PMID:22334671; http://dx.doi.org/10.1074/jbc.M111.312918.
31. Castilho A, Neumann L, Daskalova S, Mason HS, Steinkellner H, Altmann F, et al. Engineering of sialylated mucin-type O-glycosylation in plants. J Biol Chem 2012; 287:36518-36526; PMID:22948156; http://dx.doi.org/10.1074/jbc.M112.402685.
32. Daskalova SM, Radder JE, Cichacz ZA, Olsen SH, Tsaprailis G, Mason H, et al. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--to-wards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation. BMC Biotechnol 2010; 10:62; PMID:20735851; http://dx.doi.org/10.1186/1472-6750-10-62.
33. Yang Z, Bennett EP, Jorgensen B, Drew DP, Arigi E, Mandel U, et al. Toward stable genetic engineering of human O-glycosylation in plants. Plant Physiol 2012; 160:450-463; PMID:22791304; http://dx.doi.org/10.1104/pp.112.198200.
34. Strasser R. Challenges in O-glycan engineering of plants. Front Plant Sci 2012; 3:218; PMID:23015807; http://dx.doi.org/10.3389/fpls.2012.00218.
35. Ju T, Aryal RP, Stowell CJ, Cummings RD. Regulation of protein O-glycosylation by the endoplasmic retic-ulum-localized molecular chaperone Cosmc. J Cell Biol 2008; 182:531-542; PMID:18695044; http://dx.doi.org/10.1083/jcb.200711151.
36. Castilho A, Pabst M, Leonard R, Veit C, Altmann F, Mach L, et al. Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol 2008; 147:331-339; PMID:18326787; http://dx.doi.org/10.1104/pp.108.117572.
37. Elliott S, Egrie J, Browne J, Lorenzini T, Busse L, Rogers N, et al. Control of rHuEPO biological activity: the role of carbohydrate. Exp Hematol 2004; 32:1146-1155; PMID:15588939; http://dx.doi.org/10.1016/j.exphem.2004.08.004.
38. Leonard R, Petersen BO, Himly M, Kaar W, Wopfner N, Kolarich D, et al. Two novel types of O-glycans on the mugwort pollen allergen Art v 1 and their role in antibody binding. J Biol Chem 2005; 280:7932-7940; PMID:15591314; http://dx.doi.org/10.1074/jbc.M410407200.
39. Moriguchi R, Matsuoka C, Suyama A, Matsuoka K. Reduction of plant-specific arabinogalactan-type O-glycosylation by treating tobacco plants with ferrous chelator 2,2'-dipyridyl. Biosci Biotechnol Biochem 2011; 75:994-996; PMID:21597170; http://dx.doi.org/10.1271/bbb.100884.
40. Kornfeld S, Kornfeld R, Neufeld EF, O'Brien PJ. The feedback control of sugar nucleotide biosynthesis in liver. Proc Natl Acad Sci U S A 1964; 52:371-379; PMID:14206604; http://dx.doi.org/10.1073/pnas.52.2.371.
41. Viswanathan K, Narang S, Hinderlich S, Lee YC, Betenbaugh MJ. Engineering intracellular CMP-sialic acid metabolism into insect cells and methods to enhance its generation. Biochemistry 2005; 44:7526-7534; PMID:15895995; http://dx.doi.org/10.1021/bi047477y.
42. Bork K, Reutter W, Weidemann W, Horstkorte R. Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells. FEBS Lett 2007; 581:4195-4198; PMID:17706199; http://dx.doi.org/10.1016/j.febslet.2007.07.060.
43. Nagels B, Van Damme EJ, Callewaert N, Zabeau L, Tavernier J, Delanghe JR, et al. Biologically active, magnICON®-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol 2012; 160:242-250; PMID:22430811; http://dx.doi.org/10.1016/j.jbiotec.2012.03.003.
44. Engler C, Gruetzner R, Kandzia R, Marillonnet S. Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. PLoS One 2009; 4:e5553; PMID:19436741; http://dx.doi.org/10.1371/journal.pone.0005553.
45. Sarrion-Perdigones A, Falconi EE, Zandalinas SI, Juárez P, Fernández-del-Carmen A, Granell A, et al. GoldenBraid: an iterative cloning system for standardized assembly of reusable genetic modules. PLoS One 2011; 6:e21622; PMID:21750718; http://dx.doi.org/10.1371/journal.pone.0021622.
46. Ju T, Otto VI, Cummings RD. The Tn antigen-structural simplicity and biological complexity. Angew Chem Int Ed Engl 2011; 50:1770-1791; PMID:21259410; http://dx.doi.org/10.1002/anie.201002313.
47. Stanley P. Golgi glycosylation. Cold Spring Harb Perspect Biol 2011; 3:3; PMID:21441588; http://dx.doi.org/10.1101/cshperspect.a005199.
48. Boevink P, Oparka K, Santa Cruz S, Martin B, Betteridge A, Hawes C. Stacks on tracks: the plant Golgi apparatus traffics on an actin/ER network. Plant J 1998; 15:441-447; PMID:9750355; http://dx.doi.org/10.1046/j.1365-313X.1998.00208.x.
49. Palacpac NQ, Yoshida S, Sakai H, Kimura Y, Fujiyama K, Yoshida T, et al. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc Natl Acad Sci U S A 1999; 96:4692-4697; PMID:10200324; http://dx.doi.org/10.1073/pnas.96.8.4692.
50. Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH, et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci U S A 2001; 98:2899-2904; PMID:11226338; http://dx.doi.org/10.1073/pnas.031419998.
51. Bakker H, Rouwendal GJ, Karnoup AS, Florack DE, Stoopen GM, Helsper JP, et al. An antibody produced in tobacco expressing a hybrid beta-1,4-ga-lactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci U S A 2006; 103:7577-82; PMID:16675551; http://dx.doi.org/10.1073/pnas.0600879103.
52. Vézina LP, Faye L, Lerouge P, D'Aoust MA, Marquet-Blouin E, Burel C, et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol J 2009; 7:442-455; PMID:19422604; http://dx.doi.org/10.1111/j.1467-7652.2009.00414.x.